LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis

Abstract Objective The present study was implemented to unravel the effect of lncRNA GAS5 on renal fibrosis induced by diabetic nephropathy (DN) by regulating the miR-542-3p/ERBB4 axis. Methods db/db mice were injected with lncRNA GAS5 high expression or miR-542-3p low expression related vectors. Bi...

Full description

Saved in:
Bibliographic Details
Main Authors: Qinghua Yin, Na Guo, Ruoxi Liao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-025-01593-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585527293902848
author Qinghua Yin
Na Guo
Ruoxi Liao
author_facet Qinghua Yin
Na Guo
Ruoxi Liao
author_sort Qinghua Yin
collection DOAJ
description Abstract Objective The present study was implemented to unravel the effect of lncRNA GAS5 on renal fibrosis induced by diabetic nephropathy (DN) by regulating the miR-542-3p/ERBB4 axis. Methods db/db mice were injected with lncRNA GAS5 high expression or miR-542-3p low expression related vectors. Biochemical experiments were performed to assess blood glucose level and urine protein concentration. HE, TUNEL and Masson stainings were employed to observe the cellular morphology, apoptosis, and fibrosis of renal tissues, respectively. ELISA was executed to examine the levels of IL-1β, IL-6, and TNF-α; and the superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) activities were evaluated. Bioinformatics analysis, dual-luciferase and RIP assays were performed to verify the relationship between lncRNA GAS5 and miR-542-3p, and miR-542-3p and ERBB4. Results LncRNA GAS5 and ERBB4 were lowly expressed and miR-542-3p was highly expressed in the renal tissues of DN mice. Overexpression of lncRNA GAS5 or low-expression of miR-542-3p diminished DN-induced renal fibrosis. LncRNA GAS5 could bind to miR-542-3p and miR-542-3p further modulating ERBB4 expression. Up-regulation of miR-542-3p neutralized the suppressive effect of lncRNA GAS5 overexpression and down-regulation of ERBB4 also counteracted the inhibitory impact of down-regulation of miR-542-3p on renal fibrosis in DN mice. Conclusion Up-regulation of lncRNA GAS5 alleviates renal fibrosis in DN mice via down-regulation of miR-542-3p and up-regulation of ERBB4.
format Article
id doaj-art-d9296fa267584fbd9ca6065971b725c2
institution Kabale University
issn 1758-5996
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj-art-d9296fa267584fbd9ca6065971b725c22025-01-26T12:45:31ZengBMCDiabetology & Metabolic Syndrome1758-59962025-01-0117111110.1186/s13098-025-01593-zLncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axisQinghua Yin0Na Guo1Ruoxi Liao2Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan UniversityOccupational Disease and Toxicosis/Nephrology, West China School of Public Health and West China Fourth Hospital, Sichuan UniversityDivision of Nephrology, West China Hospital of Sichuan UniversityAbstract Objective The present study was implemented to unravel the effect of lncRNA GAS5 on renal fibrosis induced by diabetic nephropathy (DN) by regulating the miR-542-3p/ERBB4 axis. Methods db/db mice were injected with lncRNA GAS5 high expression or miR-542-3p low expression related vectors. Biochemical experiments were performed to assess blood glucose level and urine protein concentration. HE, TUNEL and Masson stainings were employed to observe the cellular morphology, apoptosis, and fibrosis of renal tissues, respectively. ELISA was executed to examine the levels of IL-1β, IL-6, and TNF-α; and the superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) activities were evaluated. Bioinformatics analysis, dual-luciferase and RIP assays were performed to verify the relationship between lncRNA GAS5 and miR-542-3p, and miR-542-3p and ERBB4. Results LncRNA GAS5 and ERBB4 were lowly expressed and miR-542-3p was highly expressed in the renal tissues of DN mice. Overexpression of lncRNA GAS5 or low-expression of miR-542-3p diminished DN-induced renal fibrosis. LncRNA GAS5 could bind to miR-542-3p and miR-542-3p further modulating ERBB4 expression. Up-regulation of miR-542-3p neutralized the suppressive effect of lncRNA GAS5 overexpression and down-regulation of ERBB4 also counteracted the inhibitory impact of down-regulation of miR-542-3p on renal fibrosis in DN mice. Conclusion Up-regulation of lncRNA GAS5 alleviates renal fibrosis in DN mice via down-regulation of miR-542-3p and up-regulation of ERBB4.https://doi.org/10.1186/s13098-025-01593-zDiabetic nephropathyRenal fibrosisLncRNA GAS5miR-542-3pERBB4Blood glucose level
spellingShingle Qinghua Yin
Na Guo
Ruoxi Liao
LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
Diabetology & Metabolic Syndrome
Diabetic nephropathy
Renal fibrosis
LncRNA GAS5
miR-542-3p
ERBB4
Blood glucose level
title LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
title_full LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
title_fullStr LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
title_full_unstemmed LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
title_short LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis
title_sort lncrna gas5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the mir 542 3p erbb4 axis
topic Diabetic nephropathy
Renal fibrosis
LncRNA GAS5
miR-542-3p
ERBB4
Blood glucose level
url https://doi.org/10.1186/s13098-025-01593-z
work_keys_str_mv AT qinghuayin lncrnagas5reducesbloodglucoselevelsandalleviatesrenalfibrosisindiabeticnephropathybyregulatingthemir5423perbb4axis
AT naguo lncrnagas5reducesbloodglucoselevelsandalleviatesrenalfibrosisindiabeticnephropathybyregulatingthemir5423perbb4axis
AT ruoxiliao lncrnagas5reducesbloodglucoselevelsandalleviatesrenalfibrosisindiabeticnephropathybyregulatingthemir5423perbb4axis